Jump to content

Search the Community

Showing results for tags 'Vaccine safety'.

More search options

  • Search By Tags

    Type tags separated by commas.
  • Search By Author

Content Type


  • Discussions
    • Polio
    • Flu awareness
    • European Immunization Week, 23–29 April 2018
    • Migration and immunization
    • World Hepatitis Day, 28 July 2017
    • European Immunization Week, 24 - 30 April 2017
    • General discussions
    • Education on Immunization
    • Data visualization
    • About NITAGs
    • Research papers, articles, and reports
    • News and social media
    • Updates from partners and stakeholders
    • European Immunization Week (2016)
    • Job opportunities
    • Q&A about the site
    • Innsbruck Treffen (private forum)


  • European Immunization Week 2018
    • Planning resources - EIW 2018
    • Brochures - EIW 2018
    • Infographics - EIW 2018
    • Posters - EIW 2018
    • Banners and social media - EIW 2018
    • Meeting folders - EIW 2018
  • Flu Awareness - 2017
    • Flu Awareness Campaign Posters
  • European Immunization Week 2017
    • Planning resources - EIW 2017
    • Brochures - EIW 2017
    • Infographics - EIW 2017
    • Posters - EIW 2017
    • Banners and social media - EIW 2017
    • Meeting folders - EIW 2017
  • Flu Awareness - 2016
    • Flu Awareness Campaign Posters
  • EIW 2016
    • Planning resources
    • Posters
    • Meeting folders

Find results in...

Find results that contain...

Date Created

  • Start


Last Updated

  • Start


Filter by number of...


  • Start



About Me





Found 13 results

  1. GACVS held its 36th meeting in Geneva, Switzerland, on 7–8 June 2017. The Committee reviewed updates on the safety profiles of Bacillus Calmette-Guérin (BCG) vaccine and human papilloma virus (HPV) vaccine and pharmacovigilance planning for the pilot implementation programme for the antimalaria vaccine. Among other findings, the Committee concluded that "Ten years after introduction, global HPV vaccine uptake remains slow, and the countries that are most at risk for cervical cancer are those least likely to have introduced the vaccine. Since licensure of HPV vaccines, GACVS has found no new adverse events of concern based on many very large, high quality studies. The new data presented at this meeting have strengthened this position." Regarding BCG: "The vaccine has been shown to be consistently protective against infant tuberculous meningitis and miliary tuberculosis, and remains an important tool for the prevention of tuberculosis" See the full GACVS meeting report: http://apps.who.int/iris/bitstream/10665/255870/1/WER9228.pdf
  2. The Confederation of Meningitis Organisations (CoMO) are pleased to share the new: Vaccines Question & Answer Resource! This resource answers many of the more challenging questions surrounding vaccines including the topics of: Vaccine Manufacture and Availability Vaccine Protection Vaccine Safety View online>> Download PDF>> Please share this resource as far and wide as you consider appropriate within your professional and personal networks alike. Use the link: http://bit.ly/VaxQandA and the hashtag: #VaccinesWork CoMO's Vaccines Q&A Resource.pdf
  3. I conducted a small study in one rural area in the USA where patients have no-to-low science literacy. Among the elders, neither videos nor texts essays succeeded in withdrawing their interest to learn about viral diseases. BUT a comic book did that and more! To my knowledge, this is the first report on improving health education among old patients using comics. I’d love to see if such results are reproducible elsewhere in EU or the USA …. If someone is interested in making our small sample size bigger, that would be awesome!
  4. The European Medicines Agency supports the European Immunization Week 2017. As part of our Annual Report 2016 to be published in May this year, a doctor, a researcher, and a regulatory body’s representative shared their thoughts on vaccine hesitancy. Their main quotes are encompassed in a set of images published under Gallery -> 'EIW 2017 materials'. The .pdf version of the interview is attached to this topic. vaccines interview final.pdf
  5. Hi everyone, Many of you will have read Dr Heidi Larson's latest Vaccine Confidence Survey of 67 countries. The big story is France where 41% of respondents disagreed that vaccines are safe. France! It is truly remarkable given that many vaccines are actually developed and produced there. This is a new 'French Paradox'. Louis Pasteur must be turning in his grave... What is going on in France? Why are their results different to Denmark and Portugal and the rest of their near-neighbours? We (Vaccines Today) ran an article earlier this year about a revision of France's vaccination policy and a public consultation that was due to begin in March. It must be time for an update on that now. Would anyone like to comment here (for publication on Vaccines Today - or not) or to be interviewed on this topic? The questions are simple: - Why is France 'different'? - How is the public consultation going? - What can be done to reverse this negative sentiment? Thanks, Gary
  6. Request Your Copy Read More About Us At Vaccines Today Blog: http://www.vaccinestoday.eu/vaccines/meet-the-scientist-using-comics-to-save-lives/
  7. http://www.vaccinestoday.eu/vaccines/meet-the-scientist-using-comics-to-save-lives/
  8. European Immunization Week started in Bucharest with the event organized within the project "Vaccination a fundamental right to health", initiated by the Bucharest Medical College Foundation in collaboration with the Romanian Association for Pediatric Education in Family Practice and the Romanian Society of Microbiology and supported by the Civic Innovation Found. Dedicated to dialogue between parents – doctors – authorities, the conference was attended by family doctors, school doctors, epidemiologists and infectious disease specialists as well as representatives of state institutions involved in the vaccination process, who answered questions from parents and the media. It was a constructive debate, useful for both practitioners and parents as participants, regardless of the beliefs they came with. The widely accepted conclusion is that we need to improve communication and involvement, taking responsibility and such meetings, allowing the expression of beliefs, experiences and fears of each party involved, are taking us in that direction. Only constant, determined, united effort of all people involved in the vaccination process: parents and physicians alike, can change the current situation in Romania’s vaccination coverage and fight the real risk of re-emerging extremely severe infectious diseases. The wrong perception of the public about vaccines and vaccination’s role in maintaining the health of our children can be changed!
  9. Electronic immunisation registers – Making a difference Electronic immunisation registers are not panacea to measles elimination but they could make a difference. Measles incidence fell 73% worldwide between 2000 and 2014, from 146 to 40 cases per million population, and eradication now looms in the distance. But for decades, measles control has stalled here in Europe and we just missed yet another elimination target date. The truth is that we are in desperate need of innovation, renewed commitments and a change of tactics when it comes to measles control in Europe. Unless we do some things better and others differently, Europe is unlikely to break the chain of domestic transmission any time soon. More of the same will not graduate Europe to join the measles-free part of the world. Data for decision-making is critical and timely, accurate and detailed information on vaccination uptake over time and place is of the essence for responsive immunisation programme management. Electronic Immunisation Registers (EIR) and Immunisation Information Systems (IIS) are two commonly used terms for computerised systems that record individual vaccinations. Such systems allow managers to monitor vaccine uptake at high resolution (i.e. uptake in smaller administrative areas), rapidly investigate signals of adverse events from vaccination, and study changes in vaccine effectiveness. Web-based EIR and IIS allow for real-time recording of individual vaccinations, including bar-code identification of the unique vaccine vial that was administered to a particular recipient. The advantages for parents and others are substantial: they no longer have to safe-guard paper records of vaccinations, they can receive verified transcripts of register records on request when required by schools and employers, and they have access to a trusted source of information on vaccines and vaccination schedules. If electronic immunisation registers offer such clear benefits to both parents and programme managers, then why do not all countries in Europe invest in them? Is it because national immunisation programmes have become complacent as a result of their historic successes? Are public health managers a conservative community that worries about rocking the boat? Or are there other, more palpable challenges of a financial, technical or legislative nature that have delayed these digital developments? I would like to learn more about your opinions on this matter. And I encourage you to explore the Norwegian electronic immunisation register as an example of what a register can deliver. This database has national coverage, operates with unique personal identifiers, and covers all children in the country. Immunisation registers such as the Norwegian that are populated from birth registration and migration records produce near complete denominators, an invaluable asset for surveillance of vaccine safety and effectiveness, and a fantastic resource for programme managers. The immunisation register in Norway is called SysVak. Click on the link to find out what SysVak offers to parents and individual vaccine recipients (information available in English). Uptake of the childhood vaccination programme is reported in absolute numbers and percentage fully vaccinated children at ages 2, 9 and 16 years, and down to the level of communes. Check out the interactive database on vaccination uptake by place, year and vaccine: http://www.norgeshelsa.no/norgeshelsa/ Systems similar to the Norwegian are in operation in other European countries, including Denmark, Finland, UK, and the Netherlands. The European Centre for Disease Prevention and Control (ECDC) recently started a project aimed at sharing experiences and expertise on IIS, and to provide technical support to countries with plans to set up electronic immunisation registries. If you want to learn more about this project please send an email to info@ecdc.europa.eu. To share your thoughts on electronic immunisation registers you can join the conversation by posting a comment here.
  • Create New...